Page 9 - Pfizer
FDA paves way for Pfizer Covid-19 vaccinations in young kids
A few countries have begun using other COVID-19 vaccines in children under 12, including China, which just began vaccinations for 3-year-olds
 "FDA paves way for Pfizer Covid-19 vaccinations in young kids")
US FDA advisers back Pfizer-BioNTech Covid-19 vaccine for children
The companies have said their vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children aged 5 to 11
 "US FDA advisers back Pfizer-BioNTech Covid-19 vaccine for children")
US FDA says Pfizer Covid-19 vaccine looks effective for young kids
Federal health regulators said late Friday that kid-size doses of Pfizer's COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children
Pfizer says its Covid vaccine is 91% effective in kids of ages 5 to 11
The efficacy result is based on a trial of about 2,250 children, according to the briefing documents
 "Pfizer says its Covid vaccine is 91% effective in kids of ages 5 to 11")
US FDA clears Moderna, J&J booster shots; backs Covid-19 vaccine mixing
Pfizer and BioNTech said a booster shot of their Covid-19 vaccine restored full protection in a large study, results that are likely to bolster the argument for giving a third dose more widely
 "US FDA clears Moderna, J&J booster shots; backs Covid-19 vaccine mixing")
Top headlines: RIL shareholders approve Saudi appointment; setback for Zee
Business Standard brings you the top stories from today
 "Top headlines: RIL shareholders approve Saudi appointment; setback for Zee")
Pfizer says its booster shot is 95.6% effective against symptomatic Covid
Regulators have wrestled with how widely to use boosters as the fast-spreading delta variant drives infection rates up
Pfizer-BioNTech ask EU agency to approve vaccine for kids 5-11
Pharmaceutical company Pfizer and biotechnology company BioNTech said Friday they have requested to have their coronavirus vaccine licensed for children ages 5 to 11 across the European Union
 "Pfizer-BioNTech ask EU agency to approve vaccine for kids 5-11")
Pfizer asks US govt to allow Covid vaccine shots for kids ages 5 to 11
Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today's age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill, but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities. Pfizer announced in a tweet that it had formally filed its application with the Food and Drug Administration. Now the FDA will have to decide if there's enough evidence that the shots are safe and will work for younger children like they do for teens and adults. An independent expert panel will publicly debate the evidence on Oct. 26. One big change: Pfizer says its research shows the younger kids should get a third of the dose now given to everyone else. After their second .
 "Pfizer asks US govt to allow Covid vaccine shots for kids ages 5 to 11")
Pfizer vaccine effective against Covid hospitalisations for 6 months: Study
The study was published in The Lancet journal on Tuesday
Covid-19 pandemic: EU panel backs booster shots of Pfizer, Moderna
Those ages 18 and older can get a third dose of the Pfizer vaccine, developed with BioNTech SE, at least six months after their second shot, the European Medicines Agency said in a statement Monday
 "Covid-19 pandemic: EU panel backs booster shots of Pfizer, Moderna")
Pfizer to sell Upjohn business to Mylan Pharma for Rs 180.48 crore
The transaction in India will be closed upon receipt of regulatory approvals, Pfizer Ltd said
 "Pfizer to sell Upjohn business to Mylan Pharma for Rs 180.48 crore")
2 doses of Pfizer vax may protect kids from long Covid: Study
The US Food and Drug Administration (FDA) has approved two doses of Pfizer-BioNTech Covid-19 vaccine to be administered to children ages 12 through 15, 21 days apart.
Pfizer Covid-19 vaccine for kids may not be available until November
Pfizer has submitted research to the U.S Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November
Biden touts Pfizer booster access after CDC boss overrules panel
The Centers for Disease Control and Prevention director, Rochelle Walensky, issued a statement advising that booster shots could be given to people with the Pfizer vaccine 6 months after second shot
US FDA okays Covid booster shot for people above 65, or at high-risk
The US Food and Drug Administration (FDA) has authorised booster shots of the Pfizer Covid-19 vaccine for people aged 65 and older or at high-risk
 "US FDA okays Covid booster shot for people above 65, or at high-risk")
US CDC panel endorses Pfizer booster shot for elderly, high-risk people
A US CDC advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions
EU regulator to decide on Pfizer booster dose at the start of October
Pfizer declined to comment, while BioNTech was not available for comment
US approves third Pfizer dose for people above 65, at-risk Americans
The panel is likely to discuss guidance for physicians on how to administer the third doses
FDA approves older, Covid at-risk people for Pfizer booster shot in US
Booster doses can be given any time at least six months after a person received their second shot, says the agency.
 "FDA approves older, Covid at-risk people for Pfizer booster shot in US")
